There’s Still Time to Invest in CV-19 Vaccine Stocks

June 9, 2021

Wake Up!
Your Potential Profits Ride On How You Enter Your Trade!

If you’re a short-term trader, everything rides on how you get into your trade.

That’s the simple truth. And nobody’s talking about it... until now!

[Download Your FREE eBook]
How To Enter YOUR Next Trade The Right Way!

My name’s Lee Gettess and I’ve spent most of my 30+ year career behind the scenes… trading for myself, consulting with major institutions, and designing automated trading system for the rich & powerful.

Researching and developing makes my days just fly by, and I love what I do. I wouldn’t trade my life with anyone’s. I feel truly blessed. But something has been bothering me…

I’m not sure if it is due to an influx of new traders during the pandemic, but I have seen a lot of discussion lately that suggests to me many traders are just a little… well, sloppy… with how they enter a market...

It is extremely important. The entry is the one-and-only time you enjoy the luxury of demanding EXACTLY what you want before taking action… and it can be a real game-changer!

So, I wrote this book to help traders like you. I hope you enjoy it…

[Download FREE eBook]
How To Enter YOUR Next TradeThe Right Way!

You need to grab this free ebook now CLICK HERE.

Sincerely,
Lee Gettess

There’s Still Time to Invest in CV-19 Vaccine Stocks by Ian Cooper

Higher Interest Rates are Bad for Stock Markets by Steve Swanson

KeyPoint Market Daily by Joe Duffy

TradeWins Author Team

Tomorrow, you could begin doubling your account every single month starting with one letter.

The letter will come from a 20-year trading professional named Ian Cooper. He says, “In 2017, following my trades you would be doubling even tripling your account some months. Let me show you how.”

He will show you exactly what to do... and he’ll give you the blueprint for just $1.

Inside Trading Newsletter

Subscription Services

E-Books

Customer Satisfaction Survey 2020

There’s Still Time to Invest in CV-19 Vaccine Stocks
by Ian Cooper

In the U.S., life is beginning to return to normal.

In fact, thanks to the vaccines, daily new infections and deaths are down.

Unfortunately, it’s still a major problem for other parts of the world. As noted by The Washington Post, “The emergence of more virulent variants of the virus in countries like Brazil and India and the slowness of vaccination efforts in many places outside the West have contributed to deadly new waves. Coronavirus case counts worldwide are already higher in 2021 than they were in 2020. The death toll almost certainly will be.”

In addition, the U.S. CDC isn’t even sure how long vaccines will protect people.

As they noted, “Although vaccines are effective at keeping you from getting sick, scientists are still learning how well vaccines prevent you from spreading the virus that causes it to others, even if you do not have symptoms. Early data shows that vaccines help keep people with no symptoms from spreading it, but we are learning more as more people get vaccinated. We’re also still learning how long vaccines protect people.”

That being the case, vaccine stocks could see even more buy interest, such as Ocugen (OCGN), Pfizer (PFE), Moderna (MRNA), and Vir Technology (VIR).

Look at Ocugen for example.

The company is about to submit its emergency use authorization (EUA) application to the US FDA for its virus vaccine. “Since we have been in discussions with the FDA since late last year, we do not believe that the FDA’s recently revised guidance regarding EUAs raises any concerns about our ability to submit the EUA for COVAXIN as planned, which is currently in process and which we expect to submit to the FDA in June. We believe that the FDA’s new guidance confirms that Ocugen continues to meet all criteria for submission of an EUA.”

Higher Interest Rates are Bad for Stock Markets
by Steve Swanson

It is a basic investment tenet that investors seek to earn the highest rate of return for the lowest possible risk. Generally, higher risk opportunities provide better rates of return and vice versa.

Some of the best historical returns for investors have been earned by owning stocks. The annualized return for the S&P 500 Index (and its predecessor S&P 90 Index) between 1926 and 2012 has been about 10.08%. But stock markets also carry the higher risk of possibly losing your principle investment too. Less risky bank CD’s or government Treasuries carry almost no risk of losing principle because they are guaranteed by the government. With that guarantee however, comes a much smaller rate of return.

It is at this juncture where the struggle over asset allocation really begins.

Interest rates as defined by the Fed Funds Rate dictate what banks, corporations, and ultimately consumers pay to borrow money. For corporations, their borrowing rate affects their ability to maintain inventory, expand operations, invest in new products, or even buyout competitors. For consumers, it determines how much they will have to pay for mortgages, new cars, home improvements, education, etc.

Joe Duffy’s KeyPoint Market Daily
June 9, 2021

Elite Wall Street trader, Joe Duffy, is allowing a limited group of future-elite investors into his masterful daily trades at thousands of dollars less than what others charge.

When you join today for $1, the first month you'll receive:

Joe Duffy’s daily video newsletter with updates on what's happening in the markets that very day. Rather than watch talking heads for hours on cable, I'll get you up to speed in minutes.

You get weekend updates where I delve more into 'bigger picture' looks at the marketplace. Videos are illustrative, instructive, concise, and un-hedged. No double talk here.

And much, much more!

Check out his most recent video here:

www.tradewins.com

© Copyright 2021 TradeWins.com. All rights reserved.
TradeWins Publishing, 22C New Leicester Hwy, #117, Asheville, NC 28806
Email: support@iss-trading.com | Phone: 888-233-1431 | Fax: 888-258-4938

PLEASE READ: Auto-trading, or any broker or advisor-directed type of trading, is not supported or endorsed by TradeWins. For additional information on auto-trading, you may visit the SEC’s website: All About Auto-Trading, TradeWins does not recommend or refer subscribers to broker-dealers. You should perform your own due diligence with respect to satisfactory broker-dealers and whether to open a brokerage account. You should always consult with your own professional advisers regarding equities and options on equities trading.

1) The information provided by the newsletters, trading, training and educational products related to various markets (collectively referred to as the “Services”) is not customized or personalized to any particular risk profile or tolerance. Nor is the information published by TradeWins Publishing (“TradeWins”) a customized or personalized recommendation to buy, sell, hold, or invest in particular financial products. The Services are intended to supplement your own research and analysis.

2) TradeWins’ Services are not a solicitation or offer to buy or sell any financial products, and the Services are not intended to provide money management advice or services.

3) Past performance is not necessarily indicative of future results. Trading and investing involve substantial risk. Trading on margin carries a high level of risk, and may not be suitable for all investors. Other than the refund policy detailed elsewhere, TradeWins does not make any guarantee or other promise as to any results that may be obtained from using the Services. No person subscribing for the Services (“Subscriber”) should make any investment decision without first consulting his or her own personal financial adviser, broker or consultant. TradeWins disclaims any and all liability in the event anything contained in the Services proves to be inaccurate, incomplete or unreliable, or results in any investment or other loss by a Subscriber.

4) You should trade or invest only “risk capital” – money you can afford to lose. Trading stocks and stock options involves high risk and you can lose the entire principal amount invested or more.

5) All investments carry risk and all trading decisions made by a person remain the responsibility of that person. There is no guarantee that systems, indicators, or trading signals will result in profits or that they will not produce losses. Subscribers should fully understand all risks associated with any kind of trading or investing before engaging in such activities.

6) Some profit examples are based on hypothetical or simulated trading. This means the trades are not actual trades and instead are hypothetical trades based on real market prices at the time the recommendation is disseminated. No actual money is invested, nor are any trades executed. Hypothetical or simulated performance is not necessarily indicative of future results. Hypothetical performance results have many inherent limitations, some of which are described below. Also, the hypothetical results do not include the costs of subscriptions, commissions, or other fees. Because the trades underlying these examples have not actually been executed, the results may understate or overstate the impact of certain market factors, such as lack of liquidity. Simulated trading services in general are also designed with the benefit of hindsight, which may not be relevant to actual trading. In addition, hypothetical trading does not involve financial risk, and no hypothetical trading record can completely account for the impact of financial risk of actual trading. TradeWins makes no representations or warranties that any account will or is likely to achieve profits similar to those shown.

7) No representation is being made that you will achieve profits or the same results as any person providing testimonial. No representation is being made that any person providing a testimonial is likely to continue to experience profitable trading after the date on which the testimonial was provided, and in fact the person providing the testimonial may have experienced losses.

8) The author experiences are not typical. The author is an experienced investor and your results will vary depending on risk tolerance, amount of risk capital utilized, size of trading position and other factors. Certain Subscribers may modify the author methods, or modify or ignore the rules or risk parameters, and any such actions are taken entirely at the Subscriber’s own election and for the Subscriber’s own risk.

If you wish to stop receiving our emails or change your subscription options, please Manage Your Subscription
TradeWins Publishing, 528 North Country Rd., St. James, NY 11780